BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mariette C, Piessen G, Briez N, Triboulet JP. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg 2008;247:365-71. [PMID: 18216546 DOI: 10.1097/SLA.0b013e31815aaadf] [Cited by in Crossref: 264] [Cited by in F6Publishing: 91] [Article Influence: 18.9] [Reference Citation Analysis]
Number Citing Articles
1 Yun JK, Kim HR, Park SI, Kim YH. Risk prediction of occult lymph node metastasis in patients with clinical T1 through T2 N0 esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 2021:S0022-5223(21)01503-8. [PMID: 34801263 DOI: 10.1016/j.jtcvs.2021.10.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 du Rieu MC, Filleron T, Beluchon B, Humeau M, Julio CH, Bloom E, Ghouti L, Kirzin S, Portier G, Pradère B, Carrère N. Recurrence risk after Ivor Lewis oesophagectomy for cancer. J Cardiothorac Surg 2013;8:215. [PMID: 24261787 DOI: 10.1186/1749-8090-8-215] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
3 Zhang H, Liang H, Gao Y, Shang X, Gong L, Ma Z, Sun K, Tang P, Yu Z. Metastatic lymph node ratio demonstrates better prognostic stratification than pN staging in patients with esophageal squamous cell carcinoma after esophagectomy. Sci Rep 2016;6:38804. [PMID: 27941828 DOI: 10.1038/srep38804] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
4 Zhao Z, Zhang Y, Wang P, Wang X, Li M. The impact of the nodal status on the overall survival of non-surgical patients with esophageal squamous cell carcinoma. Radiat Oncol 2019;14:161. [PMID: 31481064 DOI: 10.1186/s13014-019-1365-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 He W, Mao T, Yan J, Leng X, Deng X, Xie Q, Peng L, Liao Q, Scarpa M, Han Y. Moderately differentiated esophageal squamous cell carcinoma has a poor prognosis after neoadjuvant chemoradiotherapy. Ann Transl Med 2021;9:706. [PMID: 33987404 DOI: 10.21037/atm-21-1815] [Reference Citation Analysis]
6 Showalter TN, Winter KA, Berger AC, Regine WF, Abrams RA, Safran H, Hoffman JP, Benson AB, MacDonald JS, Willett CG. The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704. Int J Radiat Oncol Biol Phys. 2011;81:1328-1335. [PMID: 20934270 DOI: 10.1016/j.ijrobp.2010.07.1993] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 4.3] [Reference Citation Analysis]
7 Jang JY, Yu J, Song KJ, Jo YY, Yoo YJ, Kim SB, Park SR, Kim YH, Kim HR, Kim JH. Prognostic significance of lymph node ratio after neoadjuvant chemoradiation therapy for esophageal squamous cell carcinoma. Radiat Oncol J 2020;38:244-52. [PMID: 33233030 DOI: 10.3857/roj.2020.00850] [Reference Citation Analysis]
8 Ashfaq A, Pockaj BA, Gray RJ, Halfdanarson TR, Wasif N. Nodal counts and lymph node ratio impact survival after distal pancreatectomy for pancreatic adenocarcinoma. J Gastrointest Surg 2014;18:1929-35. [PMID: 24916590 DOI: 10.1007/s11605-014-2566-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
9 Wong J, Weber J, Almhanna K, Hoffe S, Shridhar R, Karl R, Meredith KL. Extent of lymphadenectomy does not predict survival in patients treated with primary esophagectomy. J Gastrointest Surg. 2013;17:1562-1568; discussion 1569. [PMID: 23818125 DOI: 10.1007/s11605-013-2259-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
10 Li Z, Cheng J, Zhang Y, Wen S, Lv H, Xu Y, Zhu Y, Zhang Z, Mu D, Tian Z. Comparison of Up-Front Minimally Invasive Esophagectomy versus Open Esophagectomy on Quality of Life for Esophageal Squamous Cell Cancer. Curr Oncol 2021;28:693-701. [PMID: 33503901 DOI: 10.3390/curroncol28010068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Karashima R, Watanabe M, Imamura Y, Ida S, Baba Y, Iwagami S, Miyamoto Y, Sakamoto Y, Yoshida N, Baba H. Advantages of FDG-PET/CT over CT alone in the preoperative assessment of lymph node metastasis in patients with esophageal cancer. Surg Today. 2015;45:471-477. [PMID: 24969050 DOI: 10.1007/s00595-014-0965-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
12 Elias E, Mukherji D, Faraj W, Khalife M, Dimassi H, Eloubeidi M, Hattoum H, Abou-Alfa GK, Saleh A, Shamseddine A. Lymph-node ratio is an independent prognostic factor in patients with stage III colorectal cancer: a retrospective study from the Middle East. World J Surg Oncol 2012;10:63. [PMID: 22533518 DOI: 10.1186/1477-7819-10-63] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
13 Zhao Y, Zhong S, Li Z, Zhu X, Wu F, Li Y. Pathologic lymph node ratio is a predictor of esophageal carcinoma patient survival: a literature-based pooled analysis. Oncotarget 2017;8:62231-9. [PMID: 28977940 DOI: 10.18632/oncotarget.19258] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
14 Yukawa N, Aoyama T, Tamagawa H, Tamagawa A, Atsumi Y, Kawahara S, Maezawa Y, Kano K, Murakawa M, Kazama K, Numata M, Oshima T, Masuda M, Rino Y. The Lymph Node Ratio Is an Independent Prognostic Factor in Esophageal Cancer Patients Who Receive Curative Surgery. In Vivo 2020;34:2087-93. [PMID: 32606187 DOI: 10.21873/invivo.12012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Chao YK. Extracapsular lymph node involvement in patients with esophageal cancer treated with neoadjuvant chemoradiation therapy followed by surgery: the closer you look, the less you see. J Thorac Dis 2017;9:4270-2. [PMID: 29268488 DOI: 10.21037/jtd.2017.10.53] [Reference Citation Analysis]
16 Sisic L, Blank S, Weichert W, Jäger D, Springfeld C, Hochreiter M, Büchler M, Ott K. Prognostic impact of lymph node involvement and the extent of lymphadenectomy (LAD) in adenocarcinoma of the esophagogastric junction (AEG). Langenbecks Arch Surg 2013;398:973-81. [PMID: 23887283 DOI: 10.1007/s00423-013-1101-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
17 Lee HN, Kim JI, Shin SY, Kim DH, Kim C, Hong IK. Combined CT texture analysis and nodal axial ratio for detection of nodal metastasis in esophageal cancer. Br J Radiol 2020;93:20190827. [PMID: 32242741 DOI: 10.1259/bjr.20190827] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Yang YS, Hu WP, Ni PZ, Wang WP, Yuan Y, Chen LQ. Esophageal luminal stenosis is an independent prognostic factor in esophageal squamous cell carcinoma. Oncotarget 2017;8:43397-405. [PMID: 28118615 DOI: 10.18632/oncotarget.14762] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
19 Wang N, Jia Y, Wang J, Wang X, Bao C, Song Q, Tan B, Cheng Y. Prognostic significance of lymph node ratio in esophageal cancer. Tumour Biol 2015;36:2335-41. [PMID: 25412956 DOI: 10.1007/s13277-014-2840-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
20 Merkow RP, Bentrem DJ. Importance of and adherence to lymph node staging standards in gastrointestinal cancer. Surg Oncol Clin N Am 2012;21:407-16, viii. [PMID: 22583990 DOI: 10.1016/j.soc.2012.03.010] [Reference Citation Analysis]
21 Lemini R, Díaz Vico T, Trumbull DA, Attwood K, Spaulding AC, Elli EF, Colibaseanu DT, Kukar M, Gabriel E. Prognostic models for stage I-III esophageal cancer: a comparison between existing calculators. J Gastrointest Oncol 2021;12:1963-72. [PMID: 34790364 DOI: 10.21037/jgo-20-337] [Reference Citation Analysis]
22 Wang CL, Li Y, Yue DS, Zhang LM, Zhang ZF, Sun BS. Value of the metastatic lymph node ratio for predicting the prognosis of non-small-cell lung cancer patients. World J Surg 2012;36:455-62. [PMID: 22187129 DOI: 10.1007/s00268-011-1360-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
23 Reid TD, Chan DS, Roberts SA, Crosby TD, Williams GT, Lewis WG. Prognostic significance of circumferential resection margin involvement following oesophagectomy for cancer and the predictive role of endoluminal ultrasonography. Br J Cancer 2012;107:1925-31. [PMID: 23169281 DOI: 10.1038/bjc.2012.511] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
24 Moug SJ, Saldanha JD, McGregor JR, Balsitis M, Diament RH. Positive lymph node retrieval ratio optimises patient staging in colorectal cancer. Br J Cancer 2009;100:1530-3. [PMID: 19401684 DOI: 10.1038/sj.bjc.6605049] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 4.1] [Reference Citation Analysis]
25 Zhang X, Yang Y, Sun Y, Ye B, Guo X, Mao T, Hua R, Li B, Gu H, Liu J, Li Z. Adjuvant therapy for pathological T3N0M0 esophageal squamous cell carcinoma. J Thorac Dis 2019;11:2512-22. [PMID: 31372288 DOI: 10.21037/jtd.2019.05.70] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Gu YM, Yang YS, Hu WP, Wang WP, Yuan Y, Chen LQ. Prognostic value of lymphovascular invasion in patients with esophageal squamous cell carcinoma. Ann Transl Med 2019;7:256. [PMID: 31355223 DOI: 10.21037/atm.2019.05.23] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
27 Valsangkar NP, Bush DM, Michaelson JS, Ferrone CR, Wargo JA, Lillemoe KD, Fernández-del Castillo C, Warshaw AL, Thayer SP. N0/N1, PNL, or LNR? The effect of lymph node number on accurate survival prediction in pancreatic ductal adenocarcinoma. J Gastrointest Surg. 2013;17:257-266. [PMID: 23229885 DOI: 10.1007/s11605-012-1974-7] [Cited by in Crossref: 91] [Cited by in F6Publishing: 90] [Article Influence: 9.1] [Reference Citation Analysis]
28 Akutsu Y, Matsubara H. The significance of lymph node status as a prognostic factor for esophageal cancer. Surg Today. 2011;41:1190-1195. [PMID: 21874413 DOI: 10.1007/s00595-011-4542-y] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
29 Liou DZ, Backhus LM, Lui NS, Shrager JB, Berry MF. Induction therapy for locally advanced distal esophageal adenocarcinoma: Is radiation Always necessary? J Thorac Cardiovasc Surg 2018;155:2697-707. [PMID: 29530567 DOI: 10.1016/j.jtcvs.2017.12.136] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Yang M, Zhang H, Ma Z, Gong L, Chen C, Ren P, Shang X, Tang P, Jiang H, Yu Z. Log odds of positive lymph nodes is a novel prognostic indicator for advanced ESCC after surgical resection. J Thorac Dis. 2017;9:1182-1189. [PMID: 28616267 DOI: 10.21037/jtd.2017.03.187] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
31 Samson P, Puri V, Broderick S, Patterson GA, Meyers B, Crabtree T. Extent of Lymphadenectomy Is Associated With Improved Overall Survival After Esophagectomy With or Without Induction Therapy. Ann Thorac Surg 2017;103:406-15. [PMID: 28024648 DOI: 10.1016/j.athoracsur.2016.08.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
32 Sonohara F, Gao F, Iwata N, Kanda M, Koike M, Takahashi N, Yamada Y, Kodera Y, Wang X, Goel A. Genome-wide Discovery of a Novel Gene-expression Signature for the Identification of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma. Ann Surg 2019;269:879-86. [PMID: 29240008 DOI: 10.1097/SLA.0000000000002622] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
33 Ema A, Waraya M, Yamashita K, Kokubo K, Kobayashi H, Hoshi K, Shinkai Y, Kawamata H, Nakamura K, Nishimiya H, Katada N, Watanabe M. Identification of EGFR expression status association with metastatic lymph node density (ND) by expression microarray analysis of advanced gastric cancer. Cancer Med 2015;4:90-100. [PMID: 25154973 DOI: 10.1002/cam4.311] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
34 Okumura H, Uchikado Y, Matsumoto M, Owaki T, Kita Y, Omoto I, Sasaki K, Sakurai T, Setoyama T, Nabeki B, Matsushita D, Ishigami S, Hiraki Y, Nakajo M, Natsugoe S. Prognostic factors in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiation therapy. Int J Clin Oncol 2013;18:329-34. [PMID: 22350023 DOI: 10.1007/s10147-012-0383-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
35 Twine CP, Roberts SA, Lewis WG, Dave BV, Rawlinson CE, Chan D, Robinson M, Crosby TD. Prognostic significance of endoluminal ultrasound-defined disease length and tumor volume (EDTV) for patients with the diagnosis of esophageal cancer. Surg Endosc 2010;24:870-8. [PMID: 19730945 DOI: 10.1007/s00464-009-0681-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
36 Ecker BL, Dempsey DT. In Response to "Impact of Neoadjuvant Chemoradiation on Lymph Node Status in Esophageal Cancer". Ann Surg 2017;265:e69. [PMID: 28394793 DOI: 10.1097/SLA.0000000000001262] [Reference Citation Analysis]
37 Cho JW, Choi SC, Jang JY, Shin SK, Choi KD, Lee JH, Kim SG, Sung JK, Jeon SW, Choi IJ, Kim GH, Jee SR, Lee WS, Jung HY; Korean ESD Study Group. Lymph Node Metastases in Esophageal Carcinoma: An Endoscopist's View. Clin Endosc. 2014;47:523-529. [PMID: 25505718 DOI: 10.5946/ce.2014.47.6.523] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 6.6] [Reference Citation Analysis]
38 Song Z, Wang J, Lin B, Zhang Y. Analysis of the tumor length and other prognosis factors in pT1-2 node-negative esophageal squamous cell carcinoma in a Chinese population. World J Surg Oncol. 2012;10:273. [PMID: 23249675 DOI: 10.1186/1477-7819-10-273] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
39 Liu X, Wu L, Zhang D, Lin P, Long H, Zhang L, Ma G. Prognostic impact of lymph node metastasis along the left gastric artery in esophageal squamous cell carcinoma. J Cardiothorac Surg 2021;16:124. [PMID: 33941213 DOI: 10.1186/s13019-021-01466-2] [Reference Citation Analysis]
40 Wang WP, He SL, Yang YS, Chen LQ. Strategies of nodal staging of the TNM system for esophageal cancer. Ann Transl Med 2018;6:77. [PMID: 29666800 DOI: 10.21037/atm.2017.12.17] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
41 Park IJ, Yu CS, Lim SB, Yoon YS, Kim CW, Kim TW, Kim JH, Kim JC. Ratio of metastatic lymph nodes is more important for rectal cancer patients treated with preoperative chemoradiotherapy. World J Gastroenterol 2015; 21(11): 3274-3281 [PMID: 25805934 DOI: 10.3748/wjg.v21.i11.3274] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
42 Reynolds JV, Ravi N, Muldoon C, Larkin JO, Rowley S, O'Byrne K, Hollywood D, O'Toole D. Differential pathologic variables and outcomes across the spectrum of adenocarcinoma of the esophagogastric junction. World J Surg 2010;34:2821-9. [PMID: 20827475 DOI: 10.1007/s00268-010-0783-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
43 Chen M, Liu X, Han C, Wang X, Zhao Y, Pang Q, Sun X, Li G, Zhang K, Li L, Qiao X, Lin Y, Chen J, Xiao Z. Does chemoradiotherapy benefit elderly patients with esophageal squamous cell cancer? A propensity-score matched analysis on multicenter data (3JECROG R-03A). BMC Cancer 2020;20:36. [PMID: 31941487 DOI: 10.1186/s12885-019-6461-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
44 Miller KR, Bozeman MC. Nutrition therapy issues in esophageal cancer. Curr Gastroenterol Rep 2012;14:356-66. [PMID: 22730015 DOI: 10.1007/s11894-012-0272-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
45 Hu Y, Luo KJ, Wen J, Zhu ZH. Strong expression of Id-1 in metastatic lymph nodes from esophageal squamous cell carcinoma is associated with better clinical outcome. J Thorac Dis 2018;10:5499-507. [PMID: 30416799 DOI: 10.21037/jtd.2018.09.04] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Moccia F, Tolone S, Allaria A, Napolitano V, Rosa D, Ilaria F, Ottavia M, Cesaro E, Docimo L, Fei L. Lymph Node Ratio Versus TNM System As Prognostic Factor in Colorectal Cancer Staging. a Single Center Experience. Open Med (Wars) 2019;14:523-31. [PMID: 31346549 DOI: 10.1515/med-2019-0058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
47 Jiang YX, Zhang DW, Chen Y, Sun HH, Xu SC, Gao HJ. The characteristics of oesophageal squamous cell carcinoma: an analysis of 1317 cases in southeastern China. Contemp Oncol (Pozn) 2015;19:137-41. [PMID: 26034392 DOI: 10.5114/wo.2015.51419] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Chen D, Mao Y, Xue Y, Sang Y, Liu D, Chen Y. Does the lymph node yield affect survival in patients with esophageal cancer receiving neoadjuvant therapy plus esophagectomy? A systematic review and updated meta-analysis. EClinicalMedicine 2020;25:100431. [PMID: 32775970 DOI: 10.1016/j.eclinm.2020.100431] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 Xi K, Yu H. A Comparison of the Current N2 Classification and a Modified N2 Categorization in TNM Staging of Esophageal Cancer Patients. Front Oncol 2020;10:561363. [PMID: 33552951 DOI: 10.3389/fonc.2020.561363] [Reference Citation Analysis]
50 Chen CZ, Chen JZ, Li DR, Lin ZX, Zhou MZ, Li DS, Chen ZJ. Long-term outcomes and prognostic factors for patients with esophageal cancer following radiotherapy. World J Gastroenterol 2013; 19(10): 1639-1644 [PMID: 23539205 DOI: 10.3748/wjg.v19.i10.1639] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
51 Ji X, Cai J, Chen Y, Chen LQ. Lymphatic spreading and lymphadenectomy for esophageal carcinoma. World J Gastrointest Surg 2016; 8(1): 90-94 [PMID: 26843917 DOI: 10.4240/wjgs.v8.i1.90] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
52 Kingma BF, Hadzijusufovic E, Van der Sluis PC, Bano E, Lang H, Ruurda JP, Hillegersberg van R, Grimminger PP. A structured training pathway to implement robot-assisted minimally invasive esophagectomy: the learning curve results from a high-volume center. Dis Esophagus 2020;33:doaa047. [PMID: 33241300 DOI: 10.1093/dote/doaa047] [Reference Citation Analysis]
53 Coral RV, Bigolin AV, Coral RP, Hartmann A, Dranka C, Roehe AV. Metastatic lymph node ratio, 6th or 7th AJCC edition: witch is the best lymph node classification for esophageal cancer? Prognosis factor analysis in 487 patients. Arq Bras Cir Dig 2015;28:94-7. [PMID: 26176242 DOI: 10.1590/S0102-67202015000200002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
54 Chen SB, Weng HR, Wang G, Zou XF, Liu DT, Chen YP, Zhang H. Lymph node ratio-based staging system for esophageal squamous cell carcinoma. World J Gastroenterol 2015; 21(24): 7514-7521 [PMID: 26139998 DOI: 10.3748/wjg.v21.i24.7514] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
55 Lin Z, Chen W, Chen Y, Peng X, Zhu K, Lin Y, Lin Q, Hu Z. A new classification of lymph node metastases according to the lymph node stations for predicting prognosis in surgical patients with esophageal squamous cell carcinoma. Oncotarget 2016;7:76261-73. [PMID: 27788489 DOI: 10.18632/oncotarget.12842] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
56 Donohoe CL, Phillips AW. Cancer of the esophagus and esophagogastric junction: an 8th edition staging primer. J Thorac Dis 2017;9:E282-4. [PMID: 28449521 DOI: 10.21037/jtd.2017.03.39] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
57 Hayashi Y, Xiao L, Suzuki A, Blum MA, Sabloff B, Taketa T, Maru DM, Welsh J, Lin SH, Weston B, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Ajani JA. A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer. Eur J Cancer 2012;48:3396-404. [PMID: 22853875 DOI: 10.1016/j.ejca.2012.06.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
58 Mitchell R, Kaur A, Munoh Kenne F, Khan A, Zafar W. Spontaneous Regression of Metastatic Lesions of Adenocarcinoma of the Gastro-Esophageal Junction. Cureus 2021;13:e18784. [PMID: 34796071 DOI: 10.7759/cureus.18784] [Reference Citation Analysis]
59 van Rijswijk AS, Hagens ERC, van der Peet DL, van Berge Henegouwen MI, Gisbertz SS. Differences in Esophageal Cancer Surgery in Terms of Surgical Approach and Extent of Lymphadenectomy: Findings of an International Survey. Ann Surg Oncol 2019;26:2063-72. [PMID: 30903323 DOI: 10.1245/s10434-019-07316-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
60 Mariette C, Piessen G, Vons C. [Not Available]. J Chir (Paris) 2008;145:12S21-9. [PMID: 22794068 DOI: 10.1016/S0021-7697(08)45005-6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
61 Ahmad SZ, Battoo AJ, Haji AG, Naveed S, Qurieshi MA, Mir AW, Malik TR. Patterns of Failure After Trimodal Treatment in Esophageal Squamous Cell Carcinoma: Initial Experiences from a High-Risk Endemic Area. Indian J Surg Oncol 2020;11:360-6. [PMID: 33013111 DOI: 10.1007/s13193-020-01164-w] [Reference Citation Analysis]
62 Adenis A, Tresch E, Dewas S, Romano O, Messager M, Amela E, Clisant S, Kramar A, Mariette C, Mirabel X. Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcome. BMC Cancer 2013;13:413. [PMID: 24010566 DOI: 10.1186/1471-2407-13-413] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
63 Mamdani H, Birdas T, Jalal SI. Role of surgery following neoadjuvant chemoradiation in patients with lymph node positive locally advanced esophageal adenocarcinoma: a national cancer database analysis. J Gastrointest Oncol 2021;12:1944-50. [PMID: 34790362 DOI: 10.21037/jgo-21-314] [Reference Citation Analysis]
64 Mariette C, Piessen G, Vons C. [Not Available]. J Chir (Paris) 2008;145S4:12S21-9. [PMID: 22793981 DOI: 10.1016/S0021-7697(08)74718-5] [Reference Citation Analysis]
65 Xu QR, Zhuge XP, Zhang HL, Ping YM, Chen LQ. The N-classification for esophageal cancer staging: should it be based on number, distance, or extent of the lymph node metastasis? World J Surg 2011;35:1303-10. [PMID: 21452071 DOI: 10.1007/s00268-011-1015-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
66 Li X, Xu J, Zhu L, Yang S, Yu L, Lv W, Hu J. A novel nomogram with preferable capability in predicting the overall survival of patients after radical esophageal cancer resection based on accessible clinical indicators: A comparison with AJCC staging. Cancer Med 2021;10:4228-39. [PMID: 34128338 DOI: 10.1002/cam4.3878] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
67 Komatsu Y, Orita H, Sakurada M, Maekawa H, Hoppo T, Sato K. Intraoperative blood transfusion contributes to decreased long-term survival of patients with esophageal cancer. World J Surg 2012;36:844-50. [PMID: 22350472 DOI: 10.1007/s00268-012-1433-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
68 Cavallin F, Alfieri R, Scarpa M, Cagol M, Ruol A, Fassan M, Rugge M, Ancona E, Castoro C. Nodal skip metastasis in thoracic esophageal squamous cell carcinoma: a cohort study. BMC Surg 2017;17:49. [PMID: 28464907 DOI: 10.1186/s12893-017-0247-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
69 Wang F, Gao SG, Xue Q, Tan FW, Gao YS, Mao YS, Wang DL, Zhao J, Li Y, Yu XY, Cheng H, Zhao CG, Mu JW. Log odds of positive lymph nodes is a better prognostic factor for oesophageal signet ring cell carcinoma than N stage. World J Clin Cases 2021; 9(1): 24-35 [PMID: 33511169 DOI: 10.12998/wjcc.v9.i1.24] [Reference Citation Analysis]
70 Deng XM, Zhu TY, Wang GJ, Gao BL, Wang JT, Li RX, Zhang YF, Ding HX. Lymph node metastasis pattern and significance of left gastric artery lymph node dissection in esophagectomy for esophageal cancers. World J Surg Oncol 2021;19:296. [PMID: 34635107 DOI: 10.1186/s12957-021-02405-0] [Reference Citation Analysis]
71 Wang X, Hu Y, Wu X, Liang M, Hu Z, Gan X, Li D, Cao Q, Shan H. Near-infrared fluorescence imaging-guided lymphatic mapping in thoracic esophageal cancer surgery. Surg Endosc 2021. [PMID: 34494149 DOI: 10.1007/s00464-021-08720-7] [Reference Citation Analysis]
72 Kauppila JH, Wahlin K, Lagergren P, Lagergren J. Neoadjuvant therapy in relation to lymphadenectomy and resection margins during surgery for oesophageal cancer. Sci Rep 2018;8:446. [PMID: 29323261 DOI: 10.1038/s41598-017-18879-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
73 Lee JM, Cheng JW, Lin MT, Huang PM, Chen JS, Lee YC. Is there any benefit to incorporating a laparoscopic procedure into minimally invasive esophagectomy? The impact on perioperative results in patients with esophageal cancer. World J Surg. 2011;35:790-797. [PMID: 21327605 DOI: 10.1007/s00268-011-0955-4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
74 Donlon NE, Davern M, Sheppard A, Power R, O'Connell F, Heeran AB, King R, Hayes C, Bhardwaj A, Phelan JJ, Dunne MR, Ravi N, Donohoe CL, O'Sullivan J, Reynolds JV, Lysaght J. The Prognostic Value of the Lymph Node in Oesophageal Adenocarcinoma; Incorporating Clinicopathological and Immunological Profiling. Cancers (Basel) 2021;13:4005. [PMID: 34439160 DOI: 10.3390/cancers13164005] [Reference Citation Analysis]
75 Karimata H, Shimoji H, Nishimaki T. Clinicopathological factors predicting R0 resection and long-term survival after esophagectomy in patients with T4 esophageal cancer undergoing induction chemotherapy or chemoradiotherapy. Surg Today 2015;45:479-86. [PMID: 25059344 DOI: 10.1007/s00595-014-0980-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
76 Wu H, Liu C, Xu M, Guo M, Xu S, Xie M. Prognostic value of the number of negative lymph nodes in esophageal carcinoma without lymphatic metastasis. Thorac Cancer 2018;9:1129-35. [PMID: 29952086 DOI: 10.1111/1759-7714.12796] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
77 Zhan HX, Xu JW, Wang L, Zhang GY, Hu SY. Lymph node ratio is an independent prognostic factor for patients after resection of pancreatic cancer. World J Surg Oncol 2015;13:105. [PMID: 25888902 DOI: 10.1186/s12957-015-0510-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
78 DaVee T, Ajani JA, Lee JH. Is endoscopic ultrasound examination necessary in the management of esophageal cancer? World J Gastroenterol 2017; 23(5): 751-762 [PMID: 28223720 DOI: 10.3748/wjg.v23.i5.751] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
79 Liu S, Zhu H, Li W, Zhang B, Ma L, Guo Z, Huang Y, Song P, Yu J, Guo H. Potential impact of (18)FDG-PET/CT on surgical approach for operable squamous cell cancer of middle-to-lower esophagus. Onco Targets Ther 2016;9:855-62. [PMID: 26955283 DOI: 10.2147/OTT.S97896] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
80 Partelli S, Fernandez-Del Castillo C, Bassi C, Mantovani W, Thayer SP, Crippa S, Ferrone CR, Falconi M, Pederzoli P, Warshaw AL, Salvia R. Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratio. Ann Surg 2010;251:477-82. [PMID: 20142730 DOI: 10.1097/SLA.0b013e3181cf9155] [Cited by in Crossref: 54] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
81 Favareto SL, Sousa CF, Pinto PJ, Ramos H, Chen MJ, Castro DG, Silva ML, Gondim G, Pellizzon ACA, Fogaroli RC. Clinical Prognostic Factors for Patients With Esophageal Cancer Treated With Definitive Chemoradiotherapy. Cureus 2021;13:e18894. [PMID: 34820218 DOI: 10.7759/cureus.18894] [Reference Citation Analysis]
82 Dong Y, Guan H, Huang W, Zhang Z, Zhao D, Liu Y, Zhou T, Li B. Precise delineation of clinical target volume for crossing-segments thoracic esophageal squamous cell carcinoma based on the pattern of lymph node metastases. J Thorac Dis 2015;7:2313-20. [PMID: 26793353 DOI: 10.3978/j.issn.2072-1439.2015.12.10] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
83 Zhang J, Li H, Zhou L, Yu L, Che F, Heng X. Modified nodal stage of esophageal cancer based on the evaluation of the hazard rate of the negative and positive lymph node. BMC Cancer 2020;20:1200. [PMID: 33287741 DOI: 10.1186/s12885-020-07664-w] [Reference Citation Analysis]
84 Feng Y, Wu N, Yan S, Wang X, Yang Y. Comparison of Ivor Lewis esophagectomy and Sweet esophagectomy for the treatment of middle-lower esophageal squamous cell carcinoma. J Thorac Dis 2019;11:3584-92. [PMID: 31559065 DOI: 10.21037/jtd.2019.07.68] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
85 Thomaschewski M, Hummel R, Petrova E, Knief J, Wellner UF, Keck T, Bausch D. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours. World J Gastroenterol 2018; 24(13): 1429-1439 [PMID: 29632424 DOI: 10.3748/wjg.v24.i13.1429] [Reference Citation Analysis]
86 Zhang J, Lv L, Ye Y, Jiang K, Shen Z, Wang S. Comparison of metastatic lymph node ratio staging system with the 7th AJCC system for colorectal cancer. J Cancer Res Clin Oncol. 2013;139:1947-1953. [PMID: 24057646 DOI: 10.1007/s00432-013-1525-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
87 Davies L, Mason JD, Roberts SA, Chan D, Reid TD, Robinson M, Gwynne S, Crosby TD, Lewis WG. Prognostic significance of total disease length in esophageal cancer. Surg Endosc 2012;26:2810-6. [PMID: 22534739 DOI: 10.1007/s00464-012-2250-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
88 Metzger R, Bollschweiler E, Drebber U, Mönig SP, Schröder W, Alakus H, Kocher M, Baldus SE, Hölscher AH. Neoadjuvant chemoradiotherapy for esophageal cancer: Impact on extracapsular lymph node involvement. World J Gastroenterol 2010; 16(16): 1986-1992 [PMID: 20419835 DOI: 10.3748/wjg.v16.i16.1986] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
89 Shang QX, Yang YS, Hu WP, Yuan Y, Ji AF, Chen LQ. Prognostic significance and role of thoracic lymph node metastasis based on Chinese expert consensus in esophageal cancer. Ann Transl Med 2019;7:381. [PMID: 31555695 DOI: 10.21037/atm.2019.07.63] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
90 Stroes CI, Schokker S, Molenaar RJ, Mathôt RAA, Bijlsma MF, van der Woude SO, Belo Pereira JP, Hooijer GKJ, Verhoeven RHA, Cats A, Grootscholten C, van Sandick JW, Creemers GJ, Nieuwenhuijzen GAP, Haj Mohammad N, Ruurda JP, Meijer SL, Hulshof MCCM, van Berge Henegouwen MI, van Laarhoven HWM. A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX. Cancers (Basel) 2021;13:839. [PMID: 33671266 DOI: 10.3390/cancers13040839] [Reference Citation Analysis]
91 Diaz LI, Mony S, Klapman J. Narrative review of the role of gastroenterologist in the diagnosis, treatment and palliation in gastric and gastroesophageal cancer. Ann Transl Med 2020;8:1106. [PMID: 33145325 DOI: 10.21037/atm-20-4143] [Reference Citation Analysis]
92 Xie K, Liu S, Liu J. Nomogram predicts survival benefit for non- metastatic esophageal cancer patients who underwent preoperative radiotherapy. Cancer Manag Res 2018;10:3657-68. [PMID: 30271214 DOI: 10.2147/CMAR.S165168] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
93 Pultrum BB, Honing J, Smit JK, van Dullemen HM, van Dam GM, Groen H, Hollema H, Plukker JT. A critical appraisal of circumferential resection margins in esophageal carcinoma. Ann Surg Oncol 2010;17:812-20. [PMID: 19924487 DOI: 10.1245/s10434-009-0827-4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 3.0] [Reference Citation Analysis]
94 Di Leo A, Zanoni A. Siewert III adenocarcinoma: treatment update. Updates Surg. 2017;69:319-325. [PMID: 28303519 DOI: 10.1007/s13304-017-0429-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
95 Hagens ERC, van Berge Henegouwen MI, Gisbertz SS. Distribution of Lymph Node Metastases in Esophageal Carcinoma Patients Undergoing Upfront Surgery: A Systematic Review. Cancers (Basel) 2020;12:E1592. [PMID: 32560226 DOI: 10.3390/cancers12061592] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
96 Matsuguma H, Oki I, Nakahara R, Ohata N, Igarashi S, Mori K, Endo S, Yokoi K. Proposal of new nodal classifications for non-small-cell lung cancer based on the number and ratio of metastatic lymph nodes. Eur J Cardiothorac Surg 2012;41:19-24. [PMID: 21620720 DOI: 10.1016/j.ejcts.2011.04.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 20] [Article Influence: 0.7] [Reference Citation Analysis]
97 He Z, Wu S, Li Q, Lin Q, Xu J. Use of the metastatic lymph node ratio to evaluate the prognosis of esophageal cancer patients with node metastasis following radical esophagectomy. PLoS One. 2013;8:e73446. [PMID: 24039944 DOI: 10.1371/journal.pone.0073446] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
98 Qu J, Shen C, Qin J, Wang Z, Liu Z, Guo J, Zhang H, Gao P, Bei T, Wang Y, Liu H, Kamel IR, Tian J, Li H. The MR radiomic signature can predict preoperative lymph node metastasis in patients with esophageal cancer. Eur Radiol. 2019;29:906-914. [PMID: 30039220 DOI: 10.1007/s00330-018-5583-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
99 Zheng YZ, Zhao W, Hu Y, Ding-Lin XX, Wen J, Yang H, Liu QW, Luo KJ, Huang QY, Chen JY, Fu JH. Aggressive surgical resection does not improve survival in operable esophageal squamous cell carcinoma with N2-3 status. World J Gastroenterol 2015; 21(28): 8644-8652 [PMID: 26229406 DOI: 10.3748/wjg.v21.i28.8644] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
100 Hsu WH, Hsu PK, Hsieh CC, Huang CS, Wu YC. The metastatic lymph node number and ratio are independent prognostic factors in esophageal cancer. J Gastrointest Surg. 2009;13:1913-20. [PMID: 19672664 DOI: 10.1007/s11605-009-0982-8] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 3.9] [Reference Citation Analysis]
101 Yamada S, Fujii T, Hirakawa A, Kanda M, Sugimoto H, Kodera Y. Lymph node ratio as parameter of regional lymph node involvement in pancreatic cancer. Langenbecks Arch Surg 2016;401:1143-52. [PMID: 27048402 DOI: 10.1007/s00423-016-1412-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
102 Zhang H, Yang Y, Wang W, Yuan Y, Wang Y, Chen LQ. Impact of Total Number of Lymph Node Retrieval on Patients with Esophageal Carcinoma Deserves Additional Investigation. J Gastrointest Surg 2019;23:2468. [PMID: 31515760 DOI: 10.1007/s11605-019-04397-5] [Reference Citation Analysis]
103 Yang YS, Wang YC, Deng HY, Yuan Y, Wang ZQ, He D, Chen LQ. Prognostic value of circumferential resection margin in T3N0M0 esophageal squamous cell carcinoma. Ann Transl Med 2018;6:303. [PMID: 30211191 DOI: 10.21037/atm.2018.06.49] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
104 Okamura A, Watanabe M, Yamashita K, Yuda M, Hayami M, Imamura Y, Mine S. Implication of visceral obesity in patients with esophageal squamous cell carcinoma. Langenbecks Arch Surg 2018;403:245-53. [PMID: 29196841 DOI: 10.1007/s00423-017-1643-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
105 Choi BG, Kim CY, Cho SH, Kim HJ, Koh YS, Kim JC, Cho CK, Kim HJ, Hur YH. Impact of lymph node ratio as a valuable prognostic factor in gallbladder carcinoma, focusing on stage IIIB gallbladder carcinoma. J Korean Surg Soc. 2013;84:168-177. [PMID: 23487246 DOI: 10.4174/jkss.2013.84.3.168] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]